Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
24 Apr 2024
Historique:
received: 06 12 2023
accepted: 09 04 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 25 4 2024
Statut: epublish

Résumé

This study aimed to investigate the utility of CT quantification of lung volume for predicting critical outcomes in COVID-19 patients. This retrospective cohort study included 1200 hospitalised patients with COVID-19 from 4 hospitals. Lung fields were extracted using artificial intelligence-based segmentation, and the percentage of the predicted (%pred) total lung volume (TLC (%pred)) was calculated. The incidence of critical outcomes and posthospitalisation complications was compared between patients with low and high CT lung volumes classified based on the median percentage of predicted TLC The incidence of critical outcomes was higher in the low TLC Lower CT lung volume was associated with critical outcomes, posthospitalisation complications and slower improvement of clinical conditions in COVID-19 patients.

Identifiants

pubmed: 38663888
pii: 11/1/e002234
doi: 10.1136/bmjresp-2023-002234
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Shiro Otake (S)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Yusuke Shiraishi (Y)

Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Shotaro Chubachi (S)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan bachibachi472000@z6.keio.jp.

Naoya Tanabe (N)

Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Tomoki Maetani (T)

Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takanori Asakura (T)

Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Ho Namkoong (H)

Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Takashi Shimada (T)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Shuhei Azekawa (S)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Kensuke Nakagawara (K)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Hiromu Tanaka (H)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Takahiro Fukushima (T)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Mayuko Watase (M)

Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan.

Hideki Terai (H)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Mamoru Sasaki (M)

Department of Internal Medicine, Saitama Medical Center, Tokyo, Japan.

Soichiro Ueda (S)

Department of Internal Medicine, Saitama Medical Center, Tokyo, Japan.

Yukari Kato (Y)

Division of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan.

Norihiro Harada (N)

Division of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan.

Shoji Suzuki (S)

Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.

Shuichi Yoshida (S)

Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.

Hiroki Tateno (H)

Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.

Yoshitake Yamada (Y)

Keio University Department of Radiology, Shinjuku-ku, Tokyo, Japan.

Masahiro Jinzaki (M)

Keio University Department of Radiology, Shinjuku-ku, Tokyo, Japan.

Toyohiro Hirai (T)

Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yukinori Okada (Y)

Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Genome Informatics, The University of Tokyo Graduate School of Medicine Faculty of Medicine, Bunkyo-ku, Japan.

Ryuji Koike (R)

Department of Pharmacovigilance, Tokyo Medical and Dental University, Tokyo, Japan.

Makoto Ishii (M)

Faculty of Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naoki Hasegawa (N)

Center for Infectious Diseases and Infection Control, Keio University, School of Medicine, Tokyo, Japan.

Akinori Kimura (A)

Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.

Seiya Imoto (S)

The University of Tokyo, Bunkyo-ku, Japan.

Satoru Miyano (S)

Tokyo Medical and Dental University, Bunkyo-ku, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan.
Department of Medicine, Regenerative Medicine Karolinska Institute, Stockholm, Sweden.

Takanori Kanai (T)

Division of Gastroenterology and Hepatology Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Japan.

Koichi Fukunaga (K)

ivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH